These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20663436)

  • 1. Fibroblast growth factor: will this hormone be the hemoglobin A1c for managing phosphorus balance in chronic kidney disease?
    Klonoff DC
    J Diabetes Sci Technol; 2010 Jul; 4(4):770-2. PubMed ID: 20663436
    [No Abstract]   [Full Text] [Related]  

  • 2. [Not Available].
    Ureña Torres P
    Nephrol Ther; 2015 Apr; 11(2):125-8. PubMed ID: 25814426
    [No Abstract]   [Full Text] [Related]  

  • 3. Why Is the Association of Phosphorus and FGF23 with Mortality Stronger in African-American Hemodialysis Patients.
    Lau WL; Kalantar-Zadeh K
    Am J Nephrol; 2015; 42(1):22-4. PubMed ID: 26288017
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J; Liu S; Quarles LD
    Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF-23: state of the art.
    Oliveira RB; Moysés RM
    J Bras Nefrol; 2010; 32(3):323-31. PubMed ID: 21103697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological activity of FGF-23 and pathophysiologic role in chronic kidney disease].
    Yamashita T
    Clin Calcium; 2004 May; 14(5):760-3. PubMed ID: 15577039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF23 and the parathyroid glands.
    Silver J; Naveh-Many T
    Pediatr Nephrol; 2010 Nov; 25(11):2241-5. PubMed ID: 20526631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disturbance of phosphorus metabolism in chronic kidney disease].
    Komaba H; Fukagawa M
    Clin Calcium; 2009 Feb; 19(2):166-72. PubMed ID: 19182354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is fibroblast growth factor 23 a harbinger of mortality in CKD?
    Stubbs JR; Egwuonwu S
    Pediatr Nephrol; 2012 May; 27(5):697-703. PubMed ID: 21390563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor-23 and phosphorus metabolism.
    Tiosano D
    Endocr Dev; 2011; 21():67-77. PubMed ID: 21865755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting FGF23 and phosphorus in CKD, do not forget calcium.
    Evenepoel P; Viaene L; Meijers BK
    Nephrol Dial Transplant; 2011 May; 26(5):1749-50; author reply 1750. PubMed ID: 21372258
    [No Abstract]   [Full Text] [Related]  

  • 13. Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis.
    Scialla JJ; Parekh RS; Eustace JA; Astor BC; Plantinga L; Jaar BG; Shafi T; Coresh J; Powe NR; Melamed ML
    Am J Nephrol; 2015; 42(1):25-34. PubMed ID: 26287973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease.
    Carrillo-López N; Panizo S; Alonso-Montes C; Román-García P; Rodríguez I; Martínez-Salgado C; Dusso AS; Naves M; Cannata-Andía JB
    Kidney Int; 2016 Jul; 90(1):77-89. PubMed ID: 27165819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF23/Klotho axis: phosphorus, mineral metabolism and beyond.
    Donate-Correa J; Muros-de-Fuentes M; Mora-Fernández C; Navarro-González JF
    Cytokine Growth Factor Rev; 2012; 23(1-2):37-46. PubMed ID: 22360923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast Growth Factor 23: A New Dimension to Diseases of Calcium-Phosphorus Metabolism.
    Hardcastle MR; Dittmer KE
    Vet Pathol; 2015 Sep; 52(5):770-84. PubMed ID: 26018436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of phosphorus and calcium homeostatic disorders in the development of cardiovascular events in patients with chronic renal diseases. The role of fibroblast growth factor 23 and Klotho].
    Milovanova LIu; Kozlovskaia LV; Milovanov IuS; Bobkova IN; Dobrosmyslov IA
    Ter Arkh; 2010; 82(6):66-72. PubMed ID: 20731116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease.
    Vlassara H; Uribarri J; Cai W; Goodman S; Pyzik R; Post J; Grosjean F; Woodward M; Striker GE
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):934-42. PubMed ID: 22461535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphate and FGF23 in early CKD: on how to tackle an invisible foe.
    Ketteler M; Petermann AT
    Nephrol Dial Transplant; 2011 Aug; 26(8):2430-2. PubMed ID: 21803732
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent advances in the rapidly evolving field of fibroblast growth factor 23 in chronic kidney disease.
    Zisman AL; Wolf M
    Curr Opin Nephrol Hypertens; 2010 Jul; 19(4):335-42. PubMed ID: 20583336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.